一个患有重度抑郁症和多种物质使用的患者的抽胺:一个病例报告
Abdelazim Ali1, Nahida Ahmed2, Sona Varghese2
1Psychiatry, Maudsley Health Services, Dubai, ARE.
Cureus
|October 8, 2025
概括
用于治疗耐药性抑郁症 (TRD) 的埃斯凯特胺也可能有助于减少渴望,并在同时出现物质使用障碍 (SUD) 的患者中实现戒断. 这项案例研究显示,在治疗后,抑郁症和SUD症状显著改善.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD) 和物质使用障碍 (SUDs) 经常同时发生,使治疗复杂化并恶化患者的结果.
- 胺是一种有效的治疗治疗耐药性抑郁症 (TRD),但其对SUD的影响,特别是渴望和戒断,尚不清楚.
研究的目的:
- 在患有并发性TRD和多重物质使用障碍 (SUD) 的患者中探索鼻腔以斯基坦胺的潜在双重益处.
- 评估胺对抑郁症状,渴望和从物质中戒断的影响.
主要方法:
- 一份病例报告,一名41岁的男性患有复发性MDD和多种物质使用 (阿片类药物和甲基胺),多次抗抑郁药治疗失败.
- 内鼻式胺被用作他现有的口服抗抑郁药物的辅助.
- 用患者健康问卷-9 (PHQ-9) 和对物质使用,渴望和整体功能的评估来监测患者的结果.
主要成果:
- 患者经历了显著改善的抑郁症状和显著减少渴望在一个月内胺治疗.
- 他在两个月内完全戒除了阿片类药物和甲基胺,并保持了六个月.
- 观察到显著的功能恢复,包括重返工作和创业,持续的良性情绪和六个月的禁欲. PHQ-9的分数从24下降到4.
- 埃斯凯特胺一般耐受良好,有过渡的轻微副作用,如头和分离.
结论:
- 鼻腔内胺可以为患有耐治疗抑郁症和并发性物质使用障碍的人提供双重治疗效益,解决情绪症状和物质渴望.
- 这些发现表明,胺胺的机制,可能涉及谷氨酸调节和突触可塑性,可能有助于减少渴望和改善禁欲.
- 需要进一步进行受控的临床研究来证实这些初步发现,并确定在这个患者群体中埃斯基他明的疗效和安全性.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
Electroconvulsive Therapy
891
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
891
Psychosis: Goals of Pharmacotherapy
469
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
469
Sedatives and Hypnotics Drugs: Miscellaneous Agents
515
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
515
Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242
Psychosis and Antipsychotic Drugs: Overview
816
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
816


